View/Open - Scholarly Commons Home

More documents

Recommendations

Info

disease (13% vs. 19%) and lymphoma (11% vs. 12%). Survivors with a diagnosis of a renal tumour were the one diagnostic group with a higher response than non-response rate (11% vs. 7%) but the total number was small. In general there were no differences between the groups based on treatment type (Table 2). Respondents were slightly younger at age of cancer diagnosis (5.6 years) compared to non-respondents (6.5 years, p = .02). In summary, respondents tended to be European, approximately 15 years of age, from middle to higher socio-economic backgrounds with a diagnosis of leukaemia that was treated primarily with chemotherapy. There were potentially important differences between respondents and non-respondents in ethnicity and socioeconomic status. Therefore, all analyses in the following sections have been weighted for ethnicity and socioeconomic status (New Zealand Deprivation Index 06). 38
Table 2. Socio-demographic and cancer characteristics of the childhood cancer survivor cohort and sample NZCCS Cohort Nonrespondents Respondents (n=396) (n=226) (n=170) Socio-demographic characteristics n % n % n % Gender Female 163 41 90 40 73 43 0.53 Male 233 59 136 60 97 57 Ethnicity Age European 269 68 146 65 123 72 0.07 Māori 66 17 45 20 21 12 Pacific 38 10 25 11 13 8 Asian 23 6 10 4 13 8 Median 15.4 15.3 15.4 0.8 NZ Deprivation Index 06 Low 126 32 66 29 60 35 0.05 Medium 131 33 69 31 62 36 High 138 35 90 40 48 28 Cancer Characteristics Diagnosis- ICCD-3 l Leukaemia 159 40 92 42 65 38 0.02 ll Lymphoma 47 12 28 12 19 11 lll CNS 64 16 42 19 22 13 lV Neuroblastoma 14 4 8 4 6 4 V Retinoblastoma 8 2 1 0 7 4 Vl Renal Tumours 32 9 16 7 18 11 Vll Hepatic Tumours 9 2 2 1 7 4 VIII Bone Tumours 22 6 11 5 11 6 lX Soft Tissue sarcoma 20 5 15 7 5 3 X Germ Cell/ Gonadal Tumours 8 2 2 1 6 4 Xl Epithelial /Melanoma NOS 10 3 7 3 3 2 Xll NOS malignant neoplasm 1 0 0 0 1 1 Cancer diagnosis grouped Leukaemia/Lymphoma 206 52 122 54 84 49 0.06 CNS 64 16 42 19 22 13 Other 126 32 62 27 64 38 Age at diagnosis Median 5.3 5.8 4.8 0.02 P 39
Page 1 and 2: The Self Reported Psychosocial Well
Page 3 and 4: 3.14 Confidentiality and right to p
Page 5 and 6: ATTESTATION OF AUTHORSHIP “I here
Page 7 and 8: ABSTRACT There has been increased r
Page 9 and 10: CHAPTER 1 INTRODUCTION AND OVERVIEW
Page 11 and 12: psychosocial effects intersect with
Page 13 and 14: innovative multimedia (pictures, mu
Page 15 and 16: in Twombly, 2004). The NCCS was est
Page 17 and 18: 2.1 Introduction CHAPTER 2 LITERATU
Page 19 and 20: demonstrate a higher likelihood of
Page 21 and 22: data from the Childhood Cancer Surv
Page 23 and 24: 2.6.1 Internet surveys and studies
Page 25 and 26: Aotearoa/New Zealand. The following
Page 27 and 28: could also be reported as a nested
Page 29 and 30: Table 1. Childhood cancer survivor
Page 31 and 32: answered by touch screen action wit
Page 33 and 34: The final survey questionnaire was
Page 35 and 36: 3.9 Standardized measures of psycho
Page 37 and 38: emotional, conduct problems, hypera
Page 39 and 40: programme without destabilizing exi
Page 41 and 42: approved in Crown Health Agencies
Page 43 and 44: questionnaire that was upsetting in
Page 45: 4.1 Introduction CHAPTER 4 RESULTS
Page 49 and 50: N 40 30 20 10 0 0 5 10 15 20 25 Sco
Page 51 and 52: 30 N 20 10 0 0 5 10 15 20 25 Score
Page 53 and 54: Table 4. WHO-5 score by demographic
Page 55 and 56: RT N Y Mod-severe Depression 9 1 7.
Page 57 and 58: Cancer characteristics Diagnosis CN
Page 59 and 60: Table 9. Hyperactivity by demograph
Page 61 and 62: Table 11. Prosocial Scale by demogr
Page 63 and 64: In summary, older age was associate
Page 65 and 66: 4.4.2 Comparison of depression in C
Page 67 and 68: Table 17. Comparison of SDQ prosoci
Page 69 and 70: Wells, & Scott., 2006), that report
Page 71 and 72: similar between both the study and
Page 73 and 74: 18years, when the protective factor
Page 75 and 76: parts of New Zealand have either li
Page 77 and 78: Key implications for practice inclu
Page 79 and 80: therapy do not plateau but increase
Page 81 and 82: Children's Oncology Group. (2006).
Page 83 and 84: Lusk, C., Delclos, G. L., Burau, K.
Page 85 and 86: Rosoff, P. M., Werner, C., Clipp, E
Page 87 and 88: APPENDICES 79
Page 91 and 92: Appendix B: Survey Participant Info
Page 93 and 94: Information Sheet A study of the qu
Page 95: How will I find out about the resul
Page 98 and 99:
Consent Form ACSIS: A Paediatric Ha
Page 100 and 101:
Over the last six months... I have
Page 102:
d) MASC-10 We would like to ask you
show all

View/Open - Scholarly Commons Home

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?